final exam Flashcards
Fluid volume 1kg=
1 Liter
anuria
<50 mL/24hrs of urine output
(<1-2 mL/hr)
earliest clinical manifestation of AKI
oliguria
oliguria
less than 0.5mL/hr (400mL in 24hrs)
Pathophysiology of AKI
reduced blow flow to the kidneys (shunting)
hypovolemia
hypotension
reduced cardiac output & HF
Obstruction of kidney or lower urinary tract
bilateral blood flow obstruction
RIFLE
Severity Level
Risk- decreased U/O for 6hrs; Cr 1.5
Injury- decreased U/O for 12hrs; Cr 2x baseline
Failure- anuria >12 hours; Cr 3x baseline
Outcomes levels of loss
Includes utilization of some type of renal replacement therapy
Loss (> 4 weeks)
Persistent AKI
End-stage kidney disease
>3 months of AKI
Prerenal failure
reduced blood flow to the kidney
Intrarenal/Intrinsic Failure
damage the glomeruli, interstitial tissue, or tubules
Postrenal failure
obstruction of urine flow
Prerenal Failure causes
*hypoperfusion
*FVD- GI Loss/ Hemorrhage/ renal loss (diuresis)
*Impaired Cardiac Efficiency- Cardiogenic shock (pump failure)/ dysrhythmias/ HF/ MI
*Vasodilation- anaphylaxis, sepsis (distributive shock)/antihypertensive medications
Early AKI (levels R & I) can be reversed.
prerenal clinical characteristics
decreased urine output
increased BUN/creatinine
increased urine osmolality
increased serum K+ and mag
FVD- H&H high/low. trend MAP
Intrarenal Failure causes
*Parenchymal Damage
*Prolonged Renal ischemia (2 hypoxia)- hemoglobinuria (blood trans reaction)/ rhabdo/ blocked blood flow
*Nephrotoxic Agents- aminoglycosides, NSAIDS, contrast dye/poisons/ chemo
*Infectious Processes- acute pyelonephritis/glomerulonephritis
*Disease Process- acute tubular necrosis
Intrarenal Clinical Characteristics
increased BUN/Creatinine
increased K+ & mag
often decreased urine output
increased weight
FVE
Postrenal Failure causes
-ureter, bladder, or urethral cancer, cervical cancer
-Kidney, ureter, or bladder stones
-BPH or cancer
-bladder atrophy
-calculi
-blood clots
What happens in Postrenal Failure
-obstruction distal to kidney
-pressure rises in the kidney tubules and causes decreased GFR
Postrenal Clinical Characteristics
increased BUN/ creatinine
decreased or sudden anuria
Postrenal clinical treatmeants
early intervention
relieve obstruction- surgery, cystoscopy, catheter, flush
uremia s/s
pruritis, muscle cramps, change in mental status, n/f, fatigue, anorexia, wt loss, seizures, decreased LOC, and/or MI
hyperkalemia s/s
n/v. chest pain, muscle weakness, numbness, tingling, GI pain, short QTI, peaked T wave, QRS prolongation, short PRI
Phases of Intrarenal AKI
Initiation Phase:
Begins with the initial insult and ends when oliguria develops
Oliguric Phase:
Increase in substances that SHOULD be excreted by kidneys (potassium, creatinine, urea (BUN), magnesium
Uremia s/s and hyperkalemia s/s develop
10-14 days
400 ml in 24 hours (0.5ml/kg/hr) or less
Diuretic Phase:
Gradual increase in urine output, stabilized lab values, achieve normal or elevated urine output levels
Still an altered kidney function, abnormal GFR
Recovery phase:
Can take 3-12 months to achieve this state
GFR is 1%-3% less than what it should be
Normal lab value ranges
Metabolic acidosis s/s
change in mental status, tachycardia., n/v, h/a, anorexia, fatigue -compensatory: tachypnea
AKI assessment
- Determine AKI Cause
Address Fluid Volume Status
FVE or FVD
FVD: Prerenal
FVE: Intra/Post Renal - All AKI Types
Rising BUN and Creatinine
Increased serum potassium, and phosphorous, and magnesium
Decreased serum calcium - Electrolyte management:
Hyperkalemia - Perform EKG, Cardiac Monitor
Administer sodium polystyrene (Kayexalate)
Hypocalcemia and hyperphosphatemia
Phosphorus binders: sevelamer (Renagel), lanthanum carbonate (Fosrenol)
May require temporary HD
May require calcium replacements
Address Acid/Base Imbalances
Metabolic Acidosis s/s
AKI Diagnostic findings
EKG
Renal ultrasound
Renal CT or MRI
X-ray (KUB)
Cystoscopy
Labs:
BUN
Cr
BNP
ABG
BMP (electrolytes)
U/A
Urine electrolytes
AKI medical management
- Medical Management: restore normal chemical and fluid balance
- Fluid management
Prerenal- administer IV fluids
Intra/Post Renal- fluid restriction, diuretics - Treat metabolic acidosis
- Blood pressure management
Prerenal- increase
Intra/Post- avoid hypertension - Metabolic Acidosis
ABGs, Sodium Bicarbonate administration
Decreased serum CO2 levels and decreased pH. - Renal Replacement
Dialysis
AKI prevention
AKI early identification
Prevent dehydration
Avoid hypotension
Limit exposure to nephrotoxins
Adequate fluid administration:Avoid over diuresis, maintain MAP, caution with nephrotoxic agents & IV contrast
Preserve renal function
Prevent complications
Balance FVE and FVD
Nutrition Therapy in AKI
High carbohydrate diet (limit fat intake d/t ketone production)
So carbs are used for energy, then protein can be used for tissue and muscle needs
Protein- very individualized
Limited to needed only, then increased when in diuretic phase